Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 234Carcinoma, Non-Small-Cell Lung 132Breast Neoplasms 121Glioblastoma 88Ovarian Neoplasms 86Carcinoma, Hepatocellular 69Rectal Neoplasms 64Brain Neoplasms 58Lung Neoplasms 55Neoplasm Metastasis 54Neoplasms 52Colonic Neoplasms 50Fallopian Tube Neoplasms 43Glioma 40Carcinoma, Renal Cell 35Gliosarcoma 34Melanoma 26Adenocarcinoma of Lung 26Pancreatic Neoplasms 23Liver Neoplasms 23Uterine Cervical Neoplasms 21Stomach Neoplasms 21Recurrence 21Triple Negative Breast Neoplasms 18Kidney Neoplasms 16Endometrial Neoplasms 16Esophageal Neoplasms 15Astrocytoma 14Carcinoma, Ovarian Epithelial 13Adenocarcinoma, Bronchiolo-Alveolar 13

Interventions

methyl N-acetylsibirosaminide 1Sodium Chloride 1Sildenafil Citrate 1Radiotherapy 1Prostatectomy 1Phentolamine 1Papaverine 1Oxaliplatin 1Neoprene 1Lymph Node Excision 1Hyperbaric Oxygenation 1Growth Hormone 1Dosage Forms 1Control Groups 1Capecitabine 1Bevacizumab 1Ascorbic Acid 1Alprostadil 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Postoperative Complications × Bevacizumab × Clear all
NCT00828672 2019-07-10

AXEBEAM

Universitaire Ziekenhuizen KU Leuven

Phase 2 Completed
84 enrolled 19 charts
Gastrointestinal

Postoperative Complications, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡